3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer

Chan, F C ; Potter, G A ; Barrie, S E ; Haynes, B P ; Rowlands, M G ; Houghton, J ; Jarman, M

Journal of medicinal chemistry, 1996-08, Vol.39 (17), p.3319-3323 [Periódico revisado por pares]

United States

Texto completo disponível